In vitro inhibition of CYP2D6 activity by fenfluramine.

被引：0
|
作者：
Marcucci, K
Gotschall, R
Kearns, GL
Leeder, JS
机构：
[1] Childrens Mercy Hosp, Sect Clin Pharmacol & Exp Ther, Kansas City, MO 64108 USA
[2] Childrens Mercy Hosp, NICHD, PPRU, Kansas City, MO 64108 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80099-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI99
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [21] Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population
    Ishiguro, A
    Kubota, T
    Sasaki, H
    Yamada, Y
    Iga, T
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 414 - U3
  • [22] A novel CYP2D6 scoring system for the prediction of CYP2D6 activity: Application to tamoxifen metabolism.
    Borges, S.
    Li, L.
    Robarge, J.
    Nguyen, A.
    Azzouz, F.
    Desta, Z.
    Skaar, T.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S67 - S67
  • [23] In vitro and in silico inhibition performance of choline against CYP1A2, CYP2D6 and CYP3A4
    Mateev, Emilio
    Balkanska-Mitkova, Tony
    Peikova, Lily
    Dimitrova, Maria
    Kondeva-Burdina, Magdalena
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2022, 36 (01) : 925 - 932
  • [24] Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans
    Lessard, É
    Yessine, MA
    Hamelin, BA
    Gauvin, C
    Labbé, L
    O'Hara, G
    LeBlanc, J
    Turgeon, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (02) : 175 - 184
  • [25] Pronounced inhibition of CYP2D6 activity by lopinavir/ritonavir in HIV infected patients
    Jetter, A
    Wyen, C
    Frank, D
    Aarnoutse, R
    Klaassen, T
    Abdulrazik, F
    Burger, D
    Fätkenheuer, G
    Fuhr, U
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 709 - 709
  • [26] The In Vitro Inhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine
    Zhao, Yong
    Hellum, Bent Havard
    Liang, Aihua
    Nilsen, Odd Georg
    PHYTOTHERAPY RESEARCH, 2012, 26 (02) : 277 - 283
  • [27] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
  • [28] Doxepin inhibits CYP2D6 activity in vivo
    Szewczuk-Boguslawska, M
    Kiejna, A
    Beszlej, JA
    Orzechowska-Juzwenko, K
    Milejski, P
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (04): : 491 - 494
  • [29] Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
    Livezey, Mara R.
    Briggs, Erran D.
    Bolles, Amanda K.
    Nagy, Leslie D.
    Fujiwara, Rina
    Furge, Laura Lowe
    XENOBIOTICA, 2014, 44 (04) : 309 - 319
  • [30] Assessment of CYP2D6 activity in depressed patients
    Szewczuk-Bogusawska, M
    Orzechowska-Juzwenko, K
    Milejski, P
    Beszlej, JA
    Grzesiak, M
    Kiejna, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S219 - S219
12345